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Venous Thromboembolism (VTE) is a life-threatening complication. Approximately 
900,000 people in the United States are affected by VTE with a mortality of 300,000 
cases per year. Although potentially preventable, VTE remains the leading cause of 
hospital deaths in the U.S. The practice problem addressed in the Doctor of Nursing 
Practice (DNP) project was evidence of an increased incident of VTE events on a trauma 
surgical unit. The practice-focused question evaluated the extent to which a nurse-driven 
protocol for VTE prophylaxis could improve adherence to mechanical prophylaxis with 
sequential compression devices and compliance with nursing documentation. The 
purpose for the doctoral project was to retrospectively evaluate the impact of an existing 
quality improvement (QI) project with a 3 year analysis of the VTE prevention program. 
The theoretical framework that guided the project was the Institute of Healthcare 
Improvement’s triple aim initiative to maximize healthcare performance and improve 
healthcare outcomes. The results of the Chi square inferential test show a statistically 
significant improvement when the preintervention data (N=60) were compared to the 
postintervention data (N=60) on both the presence of an order (likelihood ratio 4.236, 1 
df, p=.040). Documentation also improved from preintervention to postintervention 
(Likelihood ratio 36.69, 1df, p<.0001). Thus, the interventions set forth in  the QI project 
demonstrate successful improvement on these 2 processes measures. The impact on 
social change aligns with the The Triple Aim’s goals to optimize healthcare performance 
and reduce harm. Decreasing the incidence of VTEs support social change by promoting 









MSN, Emory University, 1998 
BSN, Brenau University, 1993 
 
Project Submitted in Partial Fulfillment 
of the Requirements for the Degree of 








This project is dedicated to my loving mother Mary Mildred Head-McClain who 
transitioned on February 12, 2005. My mother died from a pulmonary embolus secondary 
to complications of leukemia. She was a model of compassion, love, service, patience, 
and kindness. She loved humanity and was committed to serving others in need. She was 
my inspiration to pursue a career in nursing. She worked as a nursing assistant in a long 
term care facility where she was highly respected and loved for her gift of compassion 
and commitment to service. This project is also dedicated to my mom’s sisters,  Beatrice 
Head-Golden and Essie Head-DeBerry who passed away on April 1, 2020 and May 1, 
2020 respectively from the novel COVID-19 virus during the coronavirus pandemic. My 
memories of your love, support and encouragement will forever remain in my heart. I 
love and miss you all dearly! In dedication to my unconditional love and greatest 
supporter,  my wife Michelle who has been my strength and encouragement to persevere 
when adversity presented itself. To my children, Ashley, Cedric (Bianca), Jeremiah, 
Xavier, Cameron, Kyle and Kaylin for your constant love and support. To my grandsons 




I am honored to acknowledge Dr. Barbara Niedz as my project chair. I appreciate 
your commitment to excellence and your encouragement. Dr. Niedz is an incredible 
mentor who was successful in my development as a scholar and nurse leader. I would 
also like to acknowledge additional committee members Dr. Ann Hubbard, Dr. Marisa 




Table of Contents 
List of Tables ..................................................................................................................... iii 
List of Figures .................................................................................................................... iv 
Section 1: Nature of the Project ...........................................................................................1 
Introduction ....................................................................................................................1 
Problem Statement .........................................................................................................2 
Purpose ...........................................................................................................................4 
Nature of the Project ......................................................................................................5 
Significance....................................................................................................................7 
Section 2: Background and Context ..................................................................................11 
Introduction ..................................................................................................................11 
Concepts, Models, and Theories ..................................................................................12 
VTE Prophylaxis ................................................................................................... 13 
Risk Assessment ................................................................................................... 13 
Barriers to VTE Prophylaxis ................................................................................. 15 
Lean Six Sigma ..................................................................................................... 15 
Relevance to Nursing Practice .....................................................................................17 
Local Background and Context ...................................................................................18 
Role of the DNP Student..............................................................................................19 
Role of the Project Team .............................................................................................19 
Summary ......................................................................................................................20 





Sources of Evidence .....................................................................................................23 
Published Outcomes and Research ....................................................................... 23 
Archival and Operational Data ............................................................................. 24 
Evidence Generated for the Doctoral Project ....................................................... 25 
Analysis and Synthesis ................................................................................................27 
Summary ......................................................................................................................28 
Section 4: Findings and Recommendations .......................................................................29 
Introduction ..................................................................................................................29 
Findings and Implications ............................................................................................30 
Recommendations ........................................................................................................38 
Contribution of the Doctoral Project Team .................................................................39 
Strengths and Limitations of the Project ......................................................................40 
Summary ......................................................................................................................41 
Section 5: Dissemination Plan ...........................................................................................42 
Analysis of Self ............................................................................................................43 
Summary ......................................................................................................................43 
References ..........................................................................................................................45 




List of Tables 
Table 1.  Chart Audit Results (N=120) ..............................................................................31 





List of Figures 





Section 1: Nature of the Project 
Introduction 
Deep Vein Thrombosis (DVT) is the leading cause of preventable hospital deaths 
in the United States. An estimated 600,000 individuals are affected annually and one out 
of 20 will develop a DVT during their lifetime. DVT is defined as a single or multiple 
blood clots that develop in the deep veins of the extremities or pelvis with inflammation 
of the vessel wall (Meguid, 2011). Should the DVT break off and migrate to the lungs, it 
is known as a pulmonary embolus (PE). Together, a DVT and a PE are known as Venous 
Thromboembolism (VTE). VTE is a life-threatening complication for trauma patients. It 
is estimated that annually 900,000 people in the U.S. are affected by VTE and at least 
300,000 cases result in deaths each year (Dasta et al., 2015). Eppsteiner, Shin, Johnson, 
and Van (2010) reported that surgical patients without VTE prophylaxis have an 
increased risk of DVT or PE by 30%. Prophylaxis for VTE may be achieved with various 
approaches including pharmacological, mechanical, and early mobilization in 
postsurgical trauma patients. 
Reducing the incidence of VTE will promote a positive social change by guiding 
nursing practice and applying evidence-based interventions to promote human and social 
conditions. Prevention of DVT and PE is essential in reducing harm to patients, as VTE 
is an uncomfortable complication that lengthens the patient’s stay in the hospital and can 
be life-threatening. The aim of the DNP project was to retrospectively evaluate a program 
put in place to eliminate the incidence of VTE at the site, as part of an existing quality 
improvement (QI) intiative. Reducing the incidence of this hospital-acquired condition  
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will improve the patient’s hospitalized experience, and contribute to cost effectiveness at 
the DNP site, as hospital-acquired conditions are considered never events by The Centers 
for Medicare and Medicaid Services (CMS) and thus, hospitals are not fully reimbursed 
when they occur (CMS, 2020). 
Problem Statement 
VTE is the most common cause of potentially preventable deaths in hospitalized 
patients (Restrepo, Jameson & Carroll, 2015). VTE rates at a metropolitan public 
academic trauma center in the southeastern part of the United States, are four times 
higher than the benchmark of other institutions. The rate of VTE was observed to be 
increased by 30% during an 18 month period of time. A QI initiative was initiated to 
explore opportunities to decrease the rate of VTEs by identifying gaps in nursing practice 
with mechanical prophylaxis as an intervention. Noncompliance with mechanical 
prophylaxis predispose trauma surgical patients to increased risk for VTE and potential 
mortality if not prevented or treated. 
Daily hospital costs for patients with DVT are estimated at an annual cumulative 
expense from $5 million to $7.5 billion dollars (Dasta et al, 2015). In the U.S., the 
reported cost ranges from $3000 to $9500 for initial hospitalization for patients with a 
DVT. The hospital cost is determined to be the primary driver of hospital expense, 
accounting for 50% of the total cost per patient annually (Dasta et al, 2015). 
Approximately 900,000 people in the U.S. are affected by VTE and nearly 300,000 will 
experience death associated with disease. The incidence and mortality rates are projected 
to increase to nearly 2 million by 2050 if not prevented or are left untreated (Dasta et al., 
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2015). VTEs contribute to higher hospital costs, increased length of stays, and overall 
dissatisfaction in patient/family experience. 
The focus of the nursing practice problem is evidenced by the VTE incidence on 
the pilot unit. The pilot unit had an average of 17 VTE events monthly with a range of 15 
to 30 events per discharge month that were not present on admission. A QI intiative at the 
site was convened to reduce the VTE incidence on the pilot unit. Gaps in practice 
included lack of availability of sequential compression device (SCD) pumps, poor patient 
compliance with use of SCDs, and inadequate nursing documentation. Nursing 
documentation was indiscriminate, and not built into the electronic health record (EHR). 
The project assessment revealed lack of standardization of VTE prophylaxis and absence 
of any policy, procedure or nurse-driven protocol. 
The outcomes associated with VTE can be life-threatening for patients. The 
adverse outcomes include potential mortality, prolonged hospital length of stay, increased 
expense, loss of reimbursement from CMS and overall compromised patient and family 
experience (Gidwani & Bhattacharya, 2015). VTE is a preventable condition with 
appropriate assessment screens and timely pharmacological and mechanical prophylaxis. 
Nursing clinical interventions for mechanical prophylaxis include the use of SCDs. The 
local relevance to address VTE is driven by the need to improve safety, quality and 
effective delivery of care to reduce the incidence of VTE and adverse outcomes. 
The Agency for Healthcare Quality and Research (AHRQ; 2014b) reports the 
essential elements of safe VTE prevention measures in the hospital setting can be 
achieved by process redesign and standardization of practice. The impact of this 
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retrospective evaluation of an organization’s QI initiative can be realized by comparing 
data and processes prior to the organization’s QI project on the pilot unit. This DNP 
project assessed the impact on length of stay, readmission, morbidity, mortality, 
documentation, and income generation (AHRQ, 2014b). 
Purpose 
At the practice setting that is the subject of this DNP project, the gap in nursing 
practice included a lack of available devices and lack of standardized guidelines outlining 
the process from the time of physician order to daily adherence of SCD compliance by 
both nurses and patients. Nurses were faced with compliance issues when the physician 
prescribed mechanical prophylaxis with implementation of SCDs and no available 
equipment could be secured from central sterile department. Staff were encouraged to 
complete incident reports when unable to execute a physician order. In the practice 
setting, compliance with application and documentation of SCDs was low: a significant 
gap in nursing practice. Mechanical prophylaxis with use of SCDs is beneficial in 
decreasing the risk of VTE (Sadaghianloo & Dardik, 2016). 
Staff reported additional challenges in compliance with application and 
documentation of SCDs. Common challenges reported by the frontline team included 
lack of nonlicensed personnel assistance with application of SCDs to the patient, no 
specific location to document in the EHR, patient refusal of treatment, physician orders 
not displayed in nursing treatment orders, environmental services staff disposal of 
equipment at discharge, and lack of consistency in central sterile’s department with 
acquisition of equipment when needed. Development of a nurse-driven protocol to guide 
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nursing practice in DVT Prophylaxis could play a vital role in improving nursing 
documentation, increasing compliance with application of devices and hence, the 
incidence of DVTs. Reduced incidence of DVTs positively support the mission of 
Walden University in promoting positive social change by applying strategies and 
interventions that promote improvement of human and social conditions. The prevention 
of DVT and PE is critical in a high-risk patient population and prophylactic treatment 
may significantly reduce the risks in this population. VTE is a contributing cause of 
morbidity and mortality in the inpatient hospital stay. VTE Prevention remains a common 
cause of preventable deaths (Arnold et. al, 2017). 
Thus, the purpose of the DNP project was to retrospectively evaluate the impact 
of the DVT prevention program on the current DVT rate, and to make recommendations 
at the site on next steps. The guiding practice-focused question to facilitate a reduction in 
the VTE rate was: To what extent did a nurse-driven protocol for DVT prophylaxis 
improve compliance with nursing documentation of SCDs and patient adherence to 
mechanical prophylaxis with SCDs? 
Nature of the Project 
The DNP project  consisted of a retrospective program evaluation of an existing 
QI project with a 3 year analysis of the VTE prevention program. Data collection from a 
Lean Six Sigma QI project identified barriers and challenges with SCD compliance, 
nursing documentation, availability of SCD devices and increased incidence of DVTs. 
This problem is a strategic priority for the organization; the DNP project evaluated the 
impact of the QI initiative for mechanical VTE prophylaxis with SCDs. In addition, the 
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CMS along with the Joint Commission (TJC) have identified VTE as a preventable 
condition associated with a remarkably high medical expense and potentially high 
mortality rate (CMS, 2020; TJC, 2017). The CMS currently does not reimburse 
organizations for hospital-acquired injuries including VTE. Thus, the organization 
invested resources into solving this difficult problem. The goal of the VTE QI team was 
to eliminate any incidence of VTEs which are deemed as “never events” by CMS. Never 
events are conditions that are preventable in the hospital setting if best practice guidelines 
are utilized to eliminate harm occurrence. VTEs represent a patient safety issue that are 
clearly identifiably preventable and is a serious consequence should a patient develop 
while hospitalized. Complete elimination of VTE at the site was the goal; the purpose of 
the DNP project was to evaluate the impact of the interventions on the problem to 
determine progress towards the goal. 
The setting for the DNP project was a 950-bed public academic Level I Trauma 
center located in Georgia. On a 35-bed surgical trauma inpatient unit, the VTE rate 
increased by 30% from the first quarter of 2016 through the second quarter of 2017, an 
18 month period of time. Organizational QI strategies were implemented and were 
comprised of two components: (a) increasing availability of SCD devices and (b) 
implementation of a nurse-driven protocol to guide nursing compliance with SCDs 
including documentation in the EHR. The QI Project was piloted on a surgical trauma 
unit and rolled out to eight additional medical-surgical units, four intensive care units, a 
burn unit and a neurology unit. Nursing staff participated by serving in roles as 
champions specific to their assigned units. 
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The sources of evidence for the DNP project included retrospective and 
concurrent review of audits downloaded from EHR documentation data and monthly 
incidence of VTE events. The program evaluation included pre- and postresults related to 
implementation of VTE QI project. The DNP project’s purpose was to evaluate a QI 
initiative that was implemented in response to an increase in patient harm events from 
VTE. The objective of the VTE program served to close the gap in practice and improve 
overall care of patients at risk for DVT by increasing availability of SCD pumps, 
standardizing documentation, estatblishing a protocol to guide practice, and ultimately 
decreasing the incidence of DVT and PE. By retrospectively reviewing the impact of the 
QI initiative on the VTE rate, the DNP project had the opportunity to expand the VTE 
prophylaxis project across the organization in all surgical areas and evaluated the QI 
initiative for next steps and recommendations. 
Significance 
The key stakeholders identified in the QI Project consisted of an interdisciplinary 
team including executive sponsor, QI specialist, QI data specialist, pharmacy, physician 
champion, frontline nursing staff, nursing educator, and central distribution. The 
stakeholders were impacted by this QI project in workflow, awareness of goal, and by 
their contribution to reducing variation in VTE prophylaxis. The stakeholders were 
critical in mapping the process to identify barriers and challenges from initial screening, 
order selection, acquisition of sequential compression devices and application to patients. 
The interprofessional collaboration was essential in improving the delivery of care to 
patients at significant risks for VTE. The engagement of the senior leadership team and 
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medical staff were beneficial in expanding the pilot from an identified surgical unit to all 
units in the patient care division. A structured framework for improvement was used to 
serve as a plan; it guided communication and helped the team to stay on task. 
The contribution of this doctoral project had significant implications in changing 
practice that aligned with the organizational goals to reduce incidence of VTE and 
decrease mortality associated with VTEs. The recommendations from the American 
College of Chest Physicians (ACCP) support that in the presence of contraindications, the 
use of a low molecular weight heparin, mechanical prophylaxis is a preferred alternative. 
According to the American Association of Critical Care Nurse (2016), the process of 
prevention begins with assessment of the patient on admission for predisposing factors to 
VTE and initiation of VTE prophylaxis which aligns with the overall objectives of this 
project. 
The anticipated benefits of transferability of this project included standardization 
of clinical interventions to improve compliance with sequential compression device and 
nursing documentation with mechanical prophylaxis. Interprofessional collaboration, 
engagement, and input into the development of a nurse-driven protocol were essential in 
disseminating strategies across the health system. Implementation of a nurse-driven 
protocol was a proactive approach to improve patient care outcomes by increasing 
awareness and standardization of VTE prophylaxis. 
VTE is a significant health concern that afflicts approximately 900,000 patients in 
America yearly leading to nearly 300,000 fatalities (Dasta et al., 2015). The prevalence is 
expected to increase by more than 100% in the next 35 years (Dasta et al., 2015). 
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Critically ill patients who are administered VTE prophylaxis have a significantly reduced 
incidence of death and in a recent review of the absence of intervention, the prevalence of  
VTE in critically ill patients without prophylaxis ranges from 9 % to 32% (Adriance & 
Murphy, 2013). 
Development of a nurse-driven protocol to guide nursing practice in VTE 
prophylaxis played a vital role in improving nursing documentation, increasing 
compliance with application of devices and hence, decreasing the incidence of DVTs. 
Reduced incidence of DVTs positively supports the mission of Walden University in 
promoting positive social change by applying strategies and interventions that promote 
improvement of human and social conditions. The prevention of VTE is critical in high-
risk patient population and prophylactic treatment may significantly reduce the risks in 
this population. VTE is a significant cause of morbidity and mortality in the inpatient 
hospital stay. VTE prevention remains a common cause of preventable deaths (Arnold et. 
al, 2017). 
Summary 
VTE is a leading cause of preventable hospital death. Over half of VTE events 
developed in outpatient settings have directly linked to a recent surgery or hospital stay 
(Centers for Disease Control and Prevention [CDC], 2018). VTEs are conditions which 
are preventable with implementation of prevention strategies mechanical prophylaxis. 
The prevention measures in the DNP project practice site were underutilized due to lack 
of available equipment and lack of processes to guide nursing practice. The result of low 
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performance in prevention measures led to negative patient outcomes with an increase in 
DVT events. 
A QI project was implemented to improve outcomes in the care of patients at risk 
for DVT and PE. Prevention strategies were implemented to include increasing supply of 
sequential compression devices, enhancements of EHR to improve nursing 
documentation, and patient education tools to increased patient compliance with SCDs. 
The purpose of the DNP project was to evaluate an existing QI project progress in 
reducing the incidence of patients developing VTE on a postsurgical trauma unit. Lack of 
prevention strategies with low compliance with mechanical prophylaxis increases the risk 
of patient harm causing VTE.  
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Section 2: Background and Context 
Introduction 
The VTE rate increased by 30% on a surgical trauma inpatient unit in a large 
public academic level 1 trauma center in Georgia. VTE is comprised of DVT and PE and 
is the leading cause of preventable hospital deaths in the United States (CDC, 2018). 
Utilization of preventive measures contributes to the reduction of VTE events (Grenall, 
2017). The practice setting implemented an improvement project to improve VTE rates 
and overall delivery of safe, quality patient care. The purpose of the DNP project was to 
conduct a retrospective program evaluation of the effectiveness of the strategies 
implemented at the site and determine the impact on the VTE rate. The guiding practice-
focused question addressed the lack of compliance with SCDs. The practice question 
was: To what extent did a nurse-driven protocol for VTE prophylaxis improve 
compliance with nursing documentation of SCDs and patient adherence to mechanical 
prophylaxis with SCDs? VTEs are potentially preventable events that have a major 
contribution to preventing harm, cost saving the profit margin and increase overall patient 
experience. This section explores research related to the QI VTE prevention program, 
uses conceptual frameworks and concepts used to scope the project by defining the 
problem and conducting root cause analysis. In this section, the relevance to nursing 
practice was explored at a local, system, and global level providing context to the practice 
setting gap in practice, specifically low compliance in VTE prophylaxis. 
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Concepts, Models, and Theories 
The theoretical framework to guide doctoral project was the Institute for 
Healthcare Improvement’s (IHI) triple aim initiative to maximizing healthcare 
performance. IHI’s philosophy is based on the belief that new program designs must be 
created to pursue three dimensions known as the “Triple Aim.” The Triple Aim 
represents a framework for improving healthcare delivery outcomes. The goal of IHI’s 
framework aligns three dimensions which include: improving the patient experience of 
care, improving the health of populations, and reducing the per capita cost of healthcare 
(IHI, n.d). The Triple Aim’s approach entails a systematic method to change which is 
based on six stages of pilot testing in more than 100 organizations around the world (IHI, 
n.d.). IHI recommends a process that identifies specific populations, definition of system 
aims and measures, creation of scope of work that is efficient to drive system results and 
rapid testing that is adjustable to local needs (IHI, n.d.). In the U.S., healthcare systems 
are among the most costly in the world and makes up approximately 17% of the total 
gross domestic product and are projected to reach 19.4 % by 2027 according to the 
National Healthcare Expenditure Projections, 2018-2027 (Sisko et., al, 2019). The 
concept of Triple Aim consist of a focus on individuals and families, redesign of primary 
care services, population health management, cost control and system integration and 
execution (IHI, n.d.). 
AHRQ also recommends the QI team integrate a quality framework which 
includes a risk assessment tool and appropriate selection for pharmacological and/or 
mechanical prophylaxis for VTE prophylaxis (AHRQ, 2014b). Barriers to VTE 
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prophylaxis are also important to note because of the adverse impact in achieving 
reduction in VTE rates (Suh, et al., 2017). The existing QI infrastructure included the use 
of Plan-Do-Check-Act and Lean Six Sigma methodologies. AHRQ also suggests 
knowing what support is available for the project. Ongoing QI initiatives related to VTE 
reduction by the medical staff and pharmacy, and the active journey of pursuing a 
Magnet Recognition Program were instrumental in initiating this project. TJC and CMS 
measures were also important leverage support for the project due to both agencies 
evaluation of hospitals to meet performance standards on VTE reduction (TJC, 2017).  
VTE Prophylaxis 
The ACCP addressed issues around VTE prophylaxis. The most recent published 
guidelines from 2012 recommend pharmacological prophylaxis with anticoagulants. For 
patients who have a contraindication to a pharmacological modality, chest guidelines 
recommend mechanical prophylaxis such as graduated compression stockings and SCDs 
(Grabo et al., 2018). Graduated compression and intermittent pneumatic compression 
devices work by inflating and deflating to apply intermittent pressure gradient to move 
blood flow, prevent hemostasis, and activate the fibrinolytic pathway. A systematic 
review concluded that DVT prophylaxis can significantly reduce the incidence of DVT in 
trauma patients (Ibrahim et al., 2015). 
Risk Assessment  
The recommendations for VTE-prophylaxis were based on the risk factors 
associated with the patient. The critical need and timing of VTE prophylaxis is contingent 
upon a delicate balance between the patient and procedure risks for bleeding and 
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thrombosis (Paz Rios et al., 2018). Providers who screen and assess for risk factors and 
implement prophylaxis orders must also consider a balance between VTE risks and 
bleeding risks. If risk for bleeding is elevated, pharmacological prophylaxis is typically 
contraindicated due to potential complications; thus, mechanical prophylaxis should be 
implemented. The recommendations addressing prophylaxis should include risk factors 
for VTE, bleeding risks, criteria for pharmacological and mechanical prophylaxis, and 
appropriate contraindications (Moesker et al., 2018). VTE risk assessments identify 
factors that may predispose patients to increased risks of developing a DVT or PE. Risk 
assessments for VTE prophylaxis lead to appropriate preventative measures can 
significantly reduce the number of hospital-acquired VTE events (Greenall, 2017). VTE 
prophylaxis is essential to delivery of safe, quality care.  
VTE risk assessment and prophylaxis are gold standards for care; however, they 
are largely underutilized worldwide (Henke & Pannucci, 2010). The risks associated with 
predisposition to VTE are dependant on many factors both intrinsic and extrinsic in 
nature. Intrinsic factors include lack of natural anticoagulant proteins, gene abnormalities, 
and hypercoagulable conditions. Commonly acquired risk factors include age, history of 
VTE, malignancies, obesity and specific types of medications. Additional risk factors 
include indwelling catheters, varicose veins and inflammatory bowel disease among 
others. Extrinsic factors that may also trigger VTE are trauma, surgery, infection and 
pregnancy (Henke & Pannucci, 2010). 
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Barriers to VTE Prophylaxis 
A retrospective case-control study was conducted to determine if poor compliance 
with VTE prophylaxis guidelines could lead to increase in VTE events. The study 
showed that low adherence to the ACCP guidelines for VTE prophylaxis correlated with 
a concomitant increase in hospital acquired VTEs (Suh, et al., 2017). Barriers to VTE 
prophylaxis included low risk assessment rates, absence or incorrect contraindications to 
pharmacological prophylaxis and poor documentation of mechanical prophylaxis. 
Lloyd et al. (2012) conducted a study using paper and electronic mail surveys to 
clinicians about their perceptions on the importance of DVT prophylaxis, barriers to 
guideline implementation, and interventions to optimize prophylaxis. Despite 
recommendations and guidelines that support prophylaxis, a gap in translating this 
knowledge into practice continues to lead to underutilized prophylaxis in patients at risk 
for DVTs. Results of the study showed top barriers were lack of clear indications and 
contraindications for prophylaxis and concerns about bleeding with pharmacological 
prophylaxis (Lloyd et al., 2012). 
Lean Six Sigma 
The Define-Measure-Analyze-Improve-Control (DMAIC) model of Lean Six 
Sigma was used to help understand the problems associated with the increased VTE 
events. The acronym DMAIC represents the five stages of Lean Six methodology. The 
five stages of DMAIC are similar to the stages used in Deming’s Plan-Do-Check-ACT 
Cycle (Improta, et al., 2017). The five stages of process improvement in the DMAIC 
approach are: (a) the Define phase, where the goals of increasing utilization and 
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compliance with SCDs were defined and the project charter was made; (b) the Measure 
phase, where the team shadowed a nurse at the bedside on the practice setting unit to map 
out the current process for acquisition and application of SCDs to patients when ordered, 
(c) the Analyze phase, which used the fishbone diagram (cause and effect) which showed 
there was a lack of SCD equipment in the hospital leading to lack of compliance; (d) the 
Improve phase, the phase of change, where all possible improvements were made to 
improve compliance with application of SCDs on patients at risk for DVT; and (e) the 
Control phase, where improvement measures were hardwired and sustained (Henshall, 
2017). Six Sigma, compared with other QI methods, highlights the use of statistics in an 
active way to perform data analysis (Improta et al., 2017) and seeks to reduce process 
output variation or error in a process outcome over time not to exceed 3.4 defect parts per 
million (PPM) opportunities or 3.4 defects per million opportunities (“Statistical Six 
Sigma Definition”, n.d).  
The control phase of the DMAIC cycle was used in the retrospective program evaluation 
of the DVT prophylaxis QI initiative at the site. A range of 17 to 30 VTE events per 
month was unacceptably high to the leadership at the acute care site, indicating a 
significant opportunity for improvement. Since the organization was seeking to 
continuously improve and eliminate completely patient harm related to the hospitalization 
stay, the DNP project sought to discern the progress towards zero VTE events on the pilot 
unit as a result of the QI initiative at the site.   
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Relevance to Nursing Practice 
Mechanical prophylaxis for VTE with SCDs remain the primary clinical 
intervention by nurses to prevent DVT and PE (Restrepo et al., 2015). Low compliance 
rates are very common by both nurses and patients. Nursing noncompliance with SCD 
therapy has been associated with lack of education about correct use of this therapy and 
about VTE pathophysiology. Brockheim, McAllen, Baker and Barletta (2009) reported 
survey research in surgical intensive care where 21% of the 220 nurses in the study 
reported that they have had received inadequate education on sleeve sizing, application, 
and duration of therapy. An additional reason for observed noncompliance was lack of 
available equipment. Nursing practice is pivotal in VTE prevention and research supports 
strategies to improve practice such as patient education, staff education and competency 
proficiencies in SCD therapy (Moore & Nichols-Willis, 2013). 
Evaluation of an existing QI VTE prevention program  provided information 
about some of the challenges and barriers associated with SCD non-compliance by 
nursing staff. SCDs were ordered by licensed independent providers and the bedside 
nurses place the SCDs on the patient, validating correct size and fit (Bartzak, 2018). The 
physician completes a risk screening on admission and based on risk, prescribes 
appropriate prophylaxis. It is the role of the nurse to assess, coordinate, plan, implement 
and evaluate delivery of patient care to promote healing and recovery. As part of 
nursing’s clinical intervention, SCDs are applied to the patient with appropriate education 
to patient and family. Nurses must have the resource available i.e., the SCD pump to 
effectively carry out the plan of care specific to patient’s orders. The QI VTE prevention 
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program presented in this project significantly assisted in closing the gap in practice with 
improving compliance with SCD therapy. Ultimately, the DNP project evaluated the 
effectiveness of implementing a nurse-driven protocol to provide direction and  
standardize the nurses workflow to increase compliance with SCDs, nursing 
documentation and decrease in VTE rates. 
Local Background and Context 
In the current practice area, hospital acquired  VTE rates increased by 30% from 
calendar year 2016 to 2017. The increase in VTE rates predisposed patients to potential 
mortality. The harm caused to the patients impacted by the increased VTE rates was the 
primary determinant of exploring rationale for increase, gaps in current practice assessing 
organizational methods of VTE prevention. A QI prevention program was implemented 
which yielded an increase supply of SCD pumps, integration of a nurse-driven protocol, 
enhancements in EHR, development of patient and staff education tools. 
The setting for the doctoral project was a level 1 trauma center. The hospital is an 
large public academic center with a vision to become the leading public academic health 
system in the United States. Governance of the practice setting is managed by a board of 
directors. The organization participates in a tri-annual survey by TJC for regulatory 
compliance and supports evidence-based measures to reduce VTE events. The Centers of 
Medicare and Medicaid Services are a very large payer resource requiring reporting of 
hospital acquired injuries. The annual organizational goals review include eliminating 
hospital acquired harm event to zero. The project implemented aimed to reduce the 
incidence of potentially preventable VTE events. Prior to implementation of VTE 
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prevention program, there were no existing prevention protocols or specific risk 
assessment tools. Implementation of the VTE prevention program was aimed at reducing 
VTE rates on a surgical trauma unit. 
Role of the DNP Student 
My professional context with the doctoral project began in 2017 with an 
organizational leadership development opportunity to become certified as a green belt in 
Lean Six Sigma Process Improvement. A team of interdisciplinary members were 
selected by senior leadership to identify an organizational goal performance measure to 
improve current practice. The team brainstormed for ideas and the decision was made to 
select a problem identified in my department. I was designated as the nurse facilitator for 
the proposed QI project. My department specific experience with increased VTE events 
was the primary reason for appointment to assigned role as the nurse leader for project. 
My role as the DNP project leader included analyses of data to determine if the QI project 
was successful or unsuccessful in its aim to increase compliance with SCDs, nursing 
documentation and overall decrease in VTE harm events. As the project leader, a 
secondary analyses of the practice setting’s operational and archival data was conducted 
to summarize and present findings to the senior leadership team. 
Role of the Project Team 
An interdisciplinary QI team at the site met weekly over a period of time to scope 
out the project charter and strategies to gather information to have a clear understanding 
of the problem and barriers leading to increased VTE events. The QI team used a Lean 
Six Sigma approach to identifying potential root causes for the increase in VTE rates. 
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The QI team used the DMAIC, and other tools to problem solve. The problem statement, 
background information, current state and root cause (Define, measure and analyze 
phases of DMAIC) went well . Future state was identified with an action plan (Improve 
phase). The focus of the DNP project was a continuation of the work of the QI team at 
the site, to retrospectively evaluate the impact of the DVT prophylaxis team on the actual 
VTE rate, the documentation of the protocol and the results of a chart audit on nursing 
documentation. The DNP project focused on the extent of improvement over an 18 month 
period of time, and recommendations for next steps on how to address sustainment of 
improvement initiatives (Control phase). 
Summary 
Providers, clinicians and patients’ roles in DVT prophylaxis are essential in 
closing the gap in practice. The translation of knowledge to practice is imperative in 
achieving a reduction in VTE events. Assessment of current practice and future state 
practice requires integration of evidenced-based research and guidelines to improve 
practice for patients at risk for VTE. The VTE QI project aimed to increase awareness, 
knowledge, and compliance with existing VTE guidelines to close the gap in clinical 
practice. Thus, the next section will focus on the collection and review of the evidence to 




Section 3: Collection and Analysis of Evidence 
Introduction 
VTE remains a problematic complication for the acute care setting, especially for 
surgical patients. VTE is a term used to describe DVT and PE and is the leading cause of 
postoperative preventable deaths in the United States (Restrepo et al., 2015). DVT and 
PE occur due to an alteration in physiologic conditions causing VTE or blood clots 
resulting from immobility, surgery or traumatic injury. Blood clots form because of three 
reasons: venous stasis, hypercoagulability, and venous trauma; these three reasons are 
also known as the Virchow Triad. (Greenall, 2017). VTE prevention is recognized by the 
AHRQ as the highest rank safety practice (Brockheim et al., 2009). There is 
overwhelming evidence that VTE prevention reduces complications of VTE as well as 
reduces the overall cost to health care systems. Although, there is overwhelming evidence 
to support efficacy of VTE prophylaxis, the incidence rates remain alarming. The purpose 
of this DNP Project is to retrospectively evaluate an existing QI initiative implemented to 
reduce the incidence of VTE and improve compliance with nursing documentation. 
The practice setting in which the QI program was implemented had an increase in 
VTE rate by 30% when compared to the prior year. The evidence overwhelmingly 
supported the use of preventive measures to reduce the incidence of VTEs (Grenall, 
2017). The practice setting implemented a multidisciplinary QI project to assess gaps in 
practice and evaluate for improvement opportunities. AHRQ recommended that a 
successful QI framework should include a risk assessment tool and appropriate selection 
for pharmacological and/or mechanical prophylaxis for VTE prophylaxis (AHRQ, 
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2014b). This section will review the practice setting problem of low compliance with 
SCDs and increased VTE rates, gaps in practice with identification of a practice-focused 
question. Sources of evidence are included to support and address strategies to improve 
compliance with SCDs and reduce VTE rates. A systematic review of the literature is 
presented with relevant findings to the DNP project. Archival and operational data are 
presented with associated relevance of practice setting problem. The evidence generated 
for the DNP proposal included participants, procedures and protections. This section also 
includes analysis and synthesis of system data. 
Practice-Focused Question 
The guiding practice-focused question that addressed lack of compliance with 
sequential compression devices was: To what extent did a nurse-driven protocol for VTE 
prophylaxis improve compliance with nursing documentation of SCDs and patient 
adherence to mechanical prophylaxis with SCDs? The gap in practice addressed in the 
doctoral project was available resources of SCD pumps, nursing documentation and 
patient safety and quality outcomes. VTE is a public health and preventable patient safety 
problem that can be eliminated or significantly reduced with the implementation of 
routine prevention strategies (CDC, 2019). Clinical performance is linked to 
reimbursement; therefore, healthcare providers must ensure safe and quality care is 
provided. The practice setting site’s payor mix includes 30% Medicaid and 27% 
Medicare funding according the site’s published reporting data. Poor outcomes with VTE 
events has a significant impact on reimbursement as well as costs in providing care of 
hospital acquired conditions. The CMS requires the practice setting site to report on 
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clinical quality measures as established in the Medicare Hospital Inpatient Prospective 
Payment System for Acute Care Hospitals Final Rule. VTE consists of 2 of the total 16 
clinical quality measures required for reporting (CDC, 2020). The DNP project is aimed 
at closing the gap in care of patients at risk for VTE. 
Sources of Evidence 
The purpose of the DNP project was to evaluate an existing QI initiative VTE 
prevention program to improve compliance with application of mechanical prophylaxis 
(specifically SCDs), and nursing documentation of a VTE preventive nurse-driven 
protocol. The goal of the VTE program aimed to reduce the overall incidence of hospital 
acquired VTEs. To achieve this goal, the QI team initiated an assessment strategy using 
lean six sigma methodology to collect and analyze data. Data collection and analysis 
were required to determine potential contributing factors to noncompliance in use of 
SCDs and nursing documentation on patients with physician orders for mechanical 
prophylaxis. 
Published Outcomes and Research 
The literature review for this project was comprehensive and thorough. Several 
databases were used including Cochrane Database, EBSCOhost, MEDLINE, Cumulative 
Index to Nursing and Allied Health Literature (CINAHL), Ovid Journals, PsychINFO, 
ProQuest Dissertations and Embase. Keywords used to obtain articles for the review were 
deep vein thrombosis, mechanical prophylaxis, prevention or prophylaxis, sequential 
compression devices, documentation compliance, patient compliance and nurse. A total 
of 75 articles were reviewed with 20 identified for the literature review. Within the 
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literature review of peer-reviewed scholarly journals, all publication dates from 2014 to 
2019 and all languages were included. The search provided an extensive list for best 
practice guidelines and research on strategies to improve prevention of VTE with 
pharmacological and mechanical prophylaxis. 
Archival and Operational Data 
Current processes at the organization result in accurate and ongoing data on the 
incidence of VTE at the site. The data that is reported to an external vendor and 
ultimately reported to CMS is abstracted on discharged patients with diagnosis of VTE 
that was not present on admission which is determined by an inclusion set of ICD-10 
codes captured on discharges. The patient’s chart is carefully reviewed by the quality 
department to assure that the discharge coding matches the patient’s condition and to 
strengthen validity of the data. In this DNP project, VTE rates were reviewed over a 3 
year period from 2016 to 2020. The QI project was implemented in 2017; the purpose of 
the DNP project was to retrospectively evaluate the data for a 3-year period of time to 
evaluate the impact of the QI team on VTE outcomes 18 months before and 18 months 
after the work of the QI initiative. The relevance of data from a data collection vendor 
served to establish an assessment of current VTE rates and tracking anticipated improved 
outcomes postimplementation of the VTE QI project to reduce incidence of VTEs. Data 
for VTE rates were obtained from the Quality and Patient Safety Department’s monthly 




Chart audit data were available and accessed for a 6-week period prior to the full 
implementation of the VTE prophylaxis QI team and for a 6-week period of time after 
full implementation. These data, in the form of EHR reports, after analyzed, showed 
significant impact of the VTE prophylaxis team’s work on the full implementation of the 
nurse-driven protocol in real time. Compliance with the nurse-driven protocol included 
documentation of an initial assessment of all admitted inpatients for VTE risk and 
evidence of VTE prophylaxis within 24 hours of admission to inpatient status. A review 
of physician orders on admission was used to verify compliance with risk assessment and 
prophylaxis orders within the initial 24 hrs. A review of the daily care flowsheet was 
audited to assess compliance with application of mechanical prophylaxis with SCDs and 
compliance with patient education of VTE prophylaxis. A data collection tool was 
developed to obtain baseline information. The data collection tool consisted of 7 
questions designed to collect essential information related to VTE prophylaxis. The tool 
included information on whether or not patient was admitted with a VTE, if a physician 
order for mechanical prophylaxis was present, documentation of contraindication if 
prophylaxis not ordered, presence of nursing documentation of SCD use, and SCDs 
applied within 24 hrs of admission if ordered. 
Evidence Generated for the Doctoral Project 
Participants. To present the findings of the retrospective secondary data analysis, 
as DNP project manager, a meeting with the senior leadership team was organized to 
review findings from this evaluation of the QI project for VTE prevention and my 
evaluation of it.  The participants included the Chief Nursing Officer, Executive Sponsor 
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of the VTE QI Project, Vice President of Medical-Surgical & Oncology, Vice President 
of Critical Care, Vice President of Womens & Infant Services, Vice President of Quality 
& Patient Safety, Chief of Surgery and Chief Medical Officer. 
Procedures. The project summary to the senior leadership team consisted of a 
one-hour brief overview of the QI team’s scope of project and analyses of data related to 
compliance with SCDs, nursing documentation and overall VTE rates. Results of 
secondary analysis of de-identified data included documentation from EHR; performance 
indicators and VTE complication rates as presented in archival and operational evidence. 
In addition to the slides, an executive summary of progress relative to the practice 
setting’s annual goals was included in the presentation. After the presentation, predefined 
questions (see Appendix A) were used to generate open discussion from the senior leader 
team, providing feedback on project summary and recommendations to improve or 
sustain the gains. Next steps and implications for clinical practice and social change were 
also part of the overview.   
Protections. The project followed the criteria outlined in the DNP Walden 
University Evaluation of an existing QI Program Manual. No ethical issues were 
identified that compromised completion of the program evaluation. The practice setting 
and location was generalized to insure that it is not identifiable. All organizational data 
was de-identified. The DNP project followed the institutions guidelines including 
Walden’s and site IRB policies. IRB approval was granted by the practice site and 
Walden as evidenced by IRB #06-04-20-0996202.  Walden’s IRB provided oversight of 
data analysis and results reporting. 
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Analysis and Synthesis 
Data analysis for VTE rates over the 3-year period reviewed were provided by the 
Quality Data Specialist to establish a baseline and evaluate impact of the VTE DNP 
project. Primary data source for VTE rates was the Clinical Database Resource Manual 
from discharge coding of ICD-10 codes. The rates of VTE events were tracked by using 
ICD codes VTE-6 (182) and PSI12 (126). The IC D 10 codes were measured using tools 
from an external data collection vendor. The incidence of VTE was illustrated with run 
charts to show performance over time. Run charts offer a prompt image of how 
interventions are working in relation to the baseline and are used in the presentation of 
data (see Section 4; AHRQ, 2014b). 
The DNP project evaluated the impact of increasing supply of SCD pumps and 
implementation of a nurse-driven protocol to increase compliance of SCD application 
and nursing documentation. Data collection to determine measures of success  included 
the presence of physician order for SCD; presence of SCD pumps on every patient bed; 
observation of compression therapy per physician order and documentation of SCD 
compliance by nursing staff. Data collected post implementation of protocol and 
increased availability of pumps were compared to data collected prior to improvement 
initiatives. VTE rates per calendar year were plotted on a run chart over time to show 
patterns in performance from pre and post-implementation of nurse-driven protocol. In 
the practice site, VTE events were measured by the actual number of events per month 
for internal reporting and external reporting is measured as the number of patients with a 
VTE diagnostic code per 1000 discharges. The data review were shared in the senior 
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leader presentation to support the work of DNP project and the importance of 
organizational engagement to eliminate harm events to patients during their hospital stay.  
At the conclusion of the leadership presentation, the leaders’ reaction to the qualitative 
questionnaire were used to assess effectiveness of the DNP project in aligninig with 
organizational priorties in safe patient care and overall patient experience. The reactions 
and recommendations were communicated to the VTE QI team to prioritize committee 
goals and scope of service. 
 Summary 
Venous Thromboembolism affects up to nearly one million people in the U.S. per 
year and is the leading cause of preventable hospital deaths (CDC, 2017). The gap in 
nursing practice associated with increased rates of DVTs and PEs is noncompliance with 
implementation of VTE Prophylaxis. Nurses play a critical role in the initial risk 
assessments and implementation of mechanical prophylaxis with application of 
sequential compression devices. The aim of this project was to improve compliance with 
SCDs and nursing documentation with a primary objective to improve health outcomes 
by reducing the rate of VTE in the organization. In the next section, findings and 
implications were reviewed to support closing the gaps identified in practice and improve 
goal of reducing the incidence of hospital acquired VTE. 
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Section 4: Findings and Recommendations 
Introduction 
Blood clots have devastating effects in the United States. VTE affects as many as 
900,000 Americans each year and is responsible for as many as 100,000 deaths each year 
(CDC, 2020). VTEs are the leading cause of preventable deaths in hospitals. VTE 
presents a burden on hospital expenditures costing the United States up to $10 billion 
every year. Treatment for VTE range from $15,000 to $20,000 per person and many 
times result in hospital readmission. In the hospital setting, SCDs have been proven to be 
an effective preventive measure for VTEs and recommended for adjunct therapy with 
anticoagulants (Dhakal, et al, 2019). Prophylaxis for VTE may be achieved in various 
approaches including pharmacological, mechanical and early mobilization in postsurgical 
trauma patients.   
At the practice setting that is the subject of this DNP project, the gap in nursing 
practice included lack of available devices and lack of standardized guidelines outlining 
the process from time of MD order to daily adherence of SCD compliance by both nurses 
and patients. Low compliance rates with application of SCDs by nurses were common. 
The guiding practice-focused question that addressed lack of compliance with SCDs was: 
To what extent did a nurse-driven protocol for VTE prophylaxis improve compliance 
with nursing documentation of SCDs and patient adherence to mechanical prophylaxis 
with SCDs? The purpose of the DNP project was to conduct a retrospective analysis and 
evaluation over a 3-year period from 2016 – 2019 to determine the impact of a nurse-
driven protocol on nursing documentation of SCDs, compliance of SCDs, and VTE 
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events. Data for VTE events were obtained from the Quality and Patient Safety 
Department’s monthly executive dashboard which includes monthly and annual 
performance of organizational goals. 
Chart audit data from the EHR was available and assessed pre- and 
postimplementation of the VTE prophylaxis QI Project. Descriptive statistics were used 
to analyze the data collected from the project. Descriptive statistics analyses large 
amounts of data and summarize it. It showed median and standard deviation for 
continuous data and percentage and frequency for categorical data. A comparison using 
mean and standard deviation to display impact of the QI project on outcomes pre- and 
postproject interventions of increasing availability of SCD pumps and nurse-driven 
protocol was used. 
Findings and Implications 
The findings from an analysis and synthesis of the evidence served to evaluate 
two objectives. The first objective was to determine if a nurse-driven protocol would 
improve nursing documentation compliance with the application and use of SCDs. The 
second objective was to evaluate if compliance with SCDs would have an impact on 
reducing the number of VTE events in the practice setting. The findings also revealed an 
unanticipated outcome that physicians ordered mechanical prophylaxis greater than 90% 
of the time pre- and post-VTE QI project implementation. The consistent compliance 
with MD orders were due to VTE order sets which were developed and implemented as a 
mandatory field in the EHR for all admission orders. The compliance rates for SCD 
orders by physicians support that technology had a positive impact on performance. The 
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overall results shown in Table 1 reflect a retrospective audit of 120 medical records pre- 
and postintervention. In the preintervention review of 60 medical records, only 37% of 
nursing documentation demonstrated evidence of SCD use when ordered by physician. A 
post project implementation audit was also conducted with a review of 60 medical 
records. Postimplementation findings resulted in 88% of the records audited were 
compliant with nursing documentation of SCD use when ordered by physician.  
Results of the Chi square inferential test show a statistically significant 
improvement when the preintervention data were compared to the postintervention data 
on both the presence of an order (likelihood ratio 4.236, 1df, p=.040). Documentation 
also improved from preintervention to postintervention (Likelihood ratio 36.69, 1df, 
p<.0001). Thus, the interventions of the QI team showcased in the DNP project 
demonstrate successful improvement on these two process measures.  
Table 1 
 
Chart Audit Results (N=120) 
Measure 
 






       Improvement 
PhysicianOrder 
 
       98%            100%             2% 
SCDDocumentation            37%           88%           51% 
     
 
Opportunities to further improve documentation included recommendation to 
enhance the options available for nurses to select related to SCD use. For example, 12% 
of charts with noncompliance in documentation revealed nurses provided documentation 
but selected the incorrect option. In the EHR flowsheet, the options are on, off, patient 
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refused and anticoagulation therapy in use. The option selected was anticoagulation 
therapy in use which does not provide an accurate response for mechanical prophylaxis. 
The recommendation was made to remove selection to assist in further improvements in 
documentation. 
In relation to the project’s impact on VTE events, a secondary retrospective 
analysis over a 3-year period was reviewed to assess if mechanical prophylaxis 
contributed to reduced VTE events. Data were collected 18 months prior to QI project 
implementation and 18 months after project implementation. Figure 1 and Table 2 show 
the incidence of VTE-06 which are potentially preventable VTEs acquired during 
hospitalization was reduced after project implementation.   
   
Figure 1. VTE-06 Events per year from 2016 – 2019. Potentially preventable VTE events 
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The senior leaders engaged in a discussion in response to questions that were 
developed to determine the priority of project evaluation as it related to organizational 
goals.  The senior leader team responded to the list of questions in the following manner: 
1. How does this evaluation of existing project influence performance on VTE 
Prevention? 
Discussion: The evaluation of the VTE project was very successful in 
identifying all measures implemented by the project team to reduce and 
eliminate the incidence of VTE events. The evaluation also provided essential 
information on gains made with VTE rates and opportunities to sustain gain 
and further improve VTE outcomes. Recommendations were accepted and 
senior leaders agreed to support ongoing efforts by the existing QI Team. 
2. How does our current practice reflect quality of care in VTE Prevention as it 
relates to evidence-based practice presented in summary? 
Discussion: Senior leaders discussed the improvements observed in the 
number of VTE events since implementation of the existing QI VTE project. 
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The leaders discussed the significance of implementing a nurse-driven 
protocol and the impact on nursing documentation and compliance to use of 
SCDs. The interventions implemented by the VTE team were reflective of 
evidence-based practice recommendations in the literature and supported by 
agencies and organizations that promote patient safety initiatives to reduce 
harm events, reduce cost and improve overall patient experience. 
3. How are VTE rates used at practice site?  
Discussion: Senior leaders discussed the process of reporting VTE rates to a 
third party vendor who assists organizations to transform healthcare with data-
driven solutions. The vendor’s clinical database serves as a platform to 
improve quality by benchmarking against peers to promote reducing variation 
and accelerate improvements. The CMS also require reporting of hospital 
acquired conditions that are preventable through the application of evidence-
based guidelines. The senior leaders use VTE data to determine the impact on 
reimbursement from CMS based on the Inpatient Prospective Payment System 
(IPPS). 
4. How do VTE rates relate to the organization’s annual goals? 
Discussion: Senior leaders shared the annual goals which include reduction in 
hospital acquired conditions including catheter associated urinary tract 
infections (CAUTIs), Falls with Injury, VTEs and central line associated 
bacterial infections (CLABSIs).  
5. How does VTE rates impact quality and safe patient care? 
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Discussion: VTEs cause harm and injury to paitents which adversely impact 
the quality of care, unnecessary cost to patients, increased length of stay, and 
overall dissatisfaction with hospital experience. 
6. How does VTE impact the organization financially? 
Discussion: VTEs create additional cost to patients with the necessary 
treatment and additional labs and increase in the number of days in hospital.  
VTE expenses can be estimated as high as $20,000 per patient. 
7. How does VTE impact the patient’s overall experience? 
Discussion: In addition to increased costs to patients, senior leaders presented 
that patient satisfaction is compromised for various reasons. Patients 
experiencing VTEs may experience pain, swelling and potentially death. 
8. What are the barriers to moving forward with recommendations to improve or 
sustain gains? 
Discussion: The senior leaders shared their readiness to move forward with 
recommendations to enhance improvements. Senior leaders acknowledged 
that the recommendations are budget neutral; however, the return on 
investment will create an opportunity to eliminate VTEs, lower costs of care 
and improve overall patient experience. One barrier identified was related to 
the organization’s recent experience with an internal flood which 200 SCD 
pumps were destroyed. Fortunately, the pumps were covered by insurance and 
will be replaced; however, the timeframe to re-open the closed beds from the 




 Individuals. The project was designed to evaluate an existing QI initiative to 
improve nursing documentation for SCD compliance and reduce VTE events.  
Organizations make decisions based on data. An important step in obtaining senior 
leadership buy-in, it was imperative to provide information and data regarding 
organizational performance to fully understand the impact at the patient’s overall 
experience level. Nurses were critical to success in the level of awareness and knowledge 
base of deficits, which adversely affected compliance with SCDs and documentation.  
Nurses and techs were educated on the nurse driven protocol and documentation 
requirements to meet compliance. Patients were educated on the purpose and importance 
of wearing SCDs to reduce VTEs. Patients were also educated on the signs and 
symptoms of VTEs during the initial project implementation. The significance to 
individuals was the increased awareness and knowledge to improve nursing 
documentation and clinical outcomes. Integration of a nurse-driven protocol allowed the 
patient and clinicians to utilize evidenced-based practice to guide performance. 
Institution and System. As a result of the acquisition of additional SCD pumps, 
implementation of evidenced-based practice change, development of a nurse-driven 
protocol, development of mechanical prophylaxis for VTE, enhanced flowsheets for 
nursing documentation in the EHR, development of patient education material, 
partnership created with World Thrombosis Day, and implementation of a system-wide 
VTE Committee for ongoing performance improvement the QI team demonstrated 
statistically significant improvement in SCD ordering and documentation as well as 
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decrease in the VTE rate that has been sustained over an 18 month period. The success of 
the DNP project and project questions was largely supported by the initial buy-in of all 
stakeholders including senior leadership team. As a result of the improvement, the 
organization realized cost savings as the VTE rate plummented. 
Community. VTE is a public health problem and preventable patient safety 
problem.  The project implications for the community has a significant impact on patients 
transition from hospital to home. The increased knowledge and awareness of VTE 
prevention contributes to the overall reduction in VTE events. 
Social Change. VTE is a significant health concern that afflicts approximately 
900,000 patients in America yearly leading to nearly 300,000 fatalities. Development of a 
nurse-driven protocol to guide nursing practice in VTE Prophylaxis contributed to 
improving nursing documentation, increasing compliance with application of devices and 
hence, the incidence of VTEs. Reduced incidence of VTEs positively support the mission 
of Walden University in promoting positive social change by applying strategies and 
interventions that promote improvement of human and social conditions. VTE is a 
significant cause of morbidity and mortality in the inpatient hospital stay. VTE 
Prevention remains a common cause of preventable deaths (Arnold et. al, 2017). 
During the project evaluation, an unanticipated limitation presented during a 
major flood at the practice site. As a result of local flood that occurred in the organization 
in 2020 approximately five inpatient areas were negatively impacted including damage to 
over 200 SCD pumps. The unanticipated limitation significantly and temporarily reduced 




Based on the project evaluation, implementation of a nurse-driven protocol was 
significant in improving nursing documentation of SCD compliance and reduction in 
VTE events. Recommendations to further improve compliance include updating the 
protocol to include guidance when SCDs are no longer required (i.e. when the patient is 
ambulatory and participates in mobility programs) and adding VTE education to the 
patient eduation portal. It was also recommended that Biomed conduct regularly 
scheduled preventive maintenance and inventory of SCD pumps to maintain functionality 
of pumps and accountability for inventory. A significant recommendation was made to 
the Environmental Service staff on cleaning SCD pumps when performing a  terminal 
patient room cleaning. The Environmental Services (EVS) staff turnover rate had an 
adverse effect on the cleaning process from initial project implementation. It was 
important to note that recycling of SCD tubing ceased with the onset of the COVID-19 
Pandemic. It was highly recommended that the process of recycling tubing resumed with 
recovery from COVID-19. Related to documentation, a recommendation was made for 
the VTE Committee to collaborate with nursing informatics to remove nonessential 
options from the list of selections for SCD compliance such as “anticoagulation” from the 
flowsheet for SCD use. Anticoagulation specifically refers to pharmacological 
prophylaxis and can be assessed from the medication administration record or physician 
active med orders. The final recommendation to support documentation compliance was 
to integrate components of the nurse-driven protocol in the electronic health record to 
streamline efficiency by having the required elements of compliance embedded in their 
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workflow. Currently the staff have to go to a secondary source (online policy manager) to 
review the protocol and return to electronic health record to complete documentation. 
The recommendation submitted provided solutions to address the gaps in practice that 
were not resolved with the current DNP project. 
Contribution of the Doctoral Project Team 
The doctoral project team were highly engaged in the program evaluation findings 
and recommendations. The project team consisted of the Chief Nursing Officer, Chief 
Medical Officer, Vice President of Quality and Patient Safety, Nursing Informatics, Vice 
President of Medical Surgical Nursing & Oncology, Vice President of Women’s 
Services, Physician Liaison, Director of Pharmacy and the Lean Six Sigma Coach.  The 
responsibility of the team was to provide historical context to the barriers with VTE 
events. One of the organization’s annual goal is to decrease hospital acquired conditions 
and harm events which include VTEs. The doctoral project team added VTE as a 
performance measure on the executive dashboard for monthly reporting and ultimately 
reporting to external performance improvement vendor. The project team played an 
integral role in the final recommendations by providing insight on the level of influence 
and buy-in with the DNP project and it’s impact on eliminating harm events. The project 
team also requested that the VTE Committee continue working to further understand the 
gaps in practice with physician compliance with start and stop times with anticoagulation 
during the perioperative period.  The scope of the DNP project will extend to include 
VTE Committee’s review of patient safety indicator-12 (PSI-12) which is defined as a 
VTE event associated with a perioperative procedure. 
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Strengths and Limitations of the Project 
Strengths of the DNP Project included an increase awareness, processes, 
resources, barriers, implications and financial impact of project evaluation to the 
executive team. The stake-holder buy-in at the executive level paved the way to a 
seamless process of addressing all recommendations by the project team. Additional 
strengths included the existence of a cohesive interprofessional & collaborative team 
providing valuable insight from diverse perspectives, such as identification of processes 
like comprehensive order sets that increase the opportunity for compliance in risk 
assessments on all patients admitted to the organization. The financial viability of the 
organization provided the opportunity of acquisition of SCD pumps for every inpatient 
hospital bed as part of the existing QI Project initiated in 2017. The project also showed 
statistical improvement in documentation and SCD compliance. 
A limitation of the project was the lack of evaluation at the departmental level.  
The project evaluation included sample population from all areas within patient care 
division and were not categorized by departments. Further review is warranted at the 
departmental level of specificity to provide opportunity for direct feedback and reporting 
to identified areas. Recommendations for future projects addressing VTE prophylaxis 
should include evaluation of anticoagulants start and stop times for perioperative 
procedures. In the practice site, a standardized approach to start and stop times vary from 
each specialty services.  The proposed recommendations to integrate components of the 
nurse-driven protocol into the electronic health record should be evaluated to determine 




The DNP project was essential to determine the impact of a nurse-driven protocol 
to improve nursing documentation and compliance with the use of SCDs. The 
interventions by the project team were critical to eliminate the incidence of VTEs at the 
practice site. An analysis of the data supports statistical significance in improvement in 
nursing documentation compliance, use of SCDs and reduction of VTEs. In summary, the 
program evaluation of the existing QI project to implement a nurse-driven protocol was 





Section 5: Dissemination Plan 
The findings from the project evaluation were disseminated to the Performance 
Improvement Oversight Committee which included executive membership: Chief 
Medical Officer, Chief Nursing Officer, Vice President of Quality and Patient Safety, 
Nursing Leadership, Executive Director of Education, Director of Pharmacy, Quality 
Specialists, Vice President of Medical Surgical Nursing & Oncology, Vice President of 
Women’s Services, and Physician Liaison. The dissemination plan included a brief 
executive summary of findings with recommendations for further interventions to fully 
close gap in practice. The audience selected are critical to success in continued 
achievement of organizational goals to reduce and eliminate incidence of VTEs. The 
appropriate venue for dissemination during the COVID-19 pandemic was a WebEx 
during which all participants were able to engage with and see the presentation. The 
organization’s VTE Committee was assigned to disseminate the findings and 
recommendations to the frontline staff champions. The clinical educators were assigned 
to continue integration nurse-driven protocol and provide SCD education in new 
employee orientation and ongoing annual competency validation. 
A dissemination plan was developed to include external channels to communicate 
results from the program evaluation. The dissemination plan include the publication of an 
article in the official journal of the American Nurses Association (ANA), the American 
Nurse ,which is read by 175,000 nursing professionals and also includes the opportunity 
to present at the ANA Quality and Innovation Conference. The dissemination plan also 
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includes a plan to submit a poster presentation to IHI’s National Forum on Quality 
Improvement in Healthcare. 
Analysis of Self 
The DNP project experience has been challenging but yet very rewarding. I have 
experienced tremendous growth in many areas of my life. The pursuit of the DNP 
journey has given me the opportunity to develop my role as a practitioner, scholar and 
leader. The knowledge and skills gained from this experience has led to fulfillment of the 
competencies on the DNP Essentials. As a candidate for the DNP degree, I have attained 
knowledge embedded in science and now possess the ability to influence to translate that 
knowledge from the evidence into clinical practice to improve patient outcomes. I am 
prepared as a scholar and leader to address current issues in nursing practice. The 
confidence gained has been valuable in strengthening my communication skills to 
become more effective in leading teams and facilitating processes to improve efficiency, 
reduce variation in practice and implement evidenced-based practices. I was very blessed 
not to have any challenges in completing the project. The insights gained from the overall 
experience have been instrumental in review of the literature for best practices and 
interprofessional collaboration to increase stakeholders engagement and yielding 
comprehensive interventions to influence individual, system and social influence. 
Summary 
The DNP Project provided perspective on the evaluation of an existing QI project 
to increase compliance with nursing documentation and decrease VTE events at the 
practice site. The evaluation’s conclusion showed overall improvement in both nursing 
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documentation and reduction in VTE events with implementation of a nurse-driven 
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Appendix A: Open Ended Qualitative Questionnaire 
 
 
1. How does this evaluation of existing project influence performance on 
VTE Prevention?   
 
2. How does our current practice reflect quality of care in VTE Prevention 
as it relates to evidence-based practice presented in summary?   
 
3. How is VTE rates used at practice site?   
 
4. How does VTE rates relate to the organization’s annual goals?   
 
5. How does VTE rates impact quality and safe patient care?   
 
6. How does VTE impact the organization financially?  
 
7. How does VTE impact the patient’s overall experience?   
 
8. What are the barriers to moving forward with recommendations to 
improve or sustain gains? 
 
 
 
 
